Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 70

Closed-loop spinal cord stimulation for improving walking in spinal cord injury patients

Official title: Efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients With Spinal Cord Injury

Run by Tsinghua University · NCT04969042 · Data updated 2026-11-12

This study is testing if a new type of spinal cord stimulation can help people with spinal cord injuries walk better during their rehab.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment10 (estimated)
SponsorTsinghua University
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedAugust 1, 2021
Main results expectedAugust 1, 2026
Study endsAugust 1, 2027
Registry record updatedJuly 20, 2021
Trial IDNCT04969042 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 70 with spinal cord injuries classified as AIS A, B, C, or D and lesions at T10 or above.

Probably not a fit

Patients with severe cognitive impairments, psychiatric disorders, or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of Closed-loop Functional Spinal Cord Stimulation in enhancing walking rehabilitation for patients with spinal cord injuries. The study spans approximately 12 months, including pre-implant evaluations, stimulator implantation, and rehabilitation training with stimulation. Participants will undergo a structured rehabilitation program aimed at improving their walking ability and speed. The trial involves a combination of medical interventions and physical therapy to optimize patient outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly improve walking capabilities in patients with spinal cord injuries.

How similar studies have gone: Other studies have shown promise with spinal cord stimulation techniques, but this specific closed-loop approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18\~70
* Spinal cord injury staging(AIS) A,B,C or D
* Level of lesion is T10 and above
* Distance between lesion and conus \>60mm
* Injured Time \> 3 months
* Capable of participating rehabilitation program
* Agree to comply with all conditions of the study and to attend all required study training and visits

Exclusion Criteria:

* With Obvious psychiatric disorder that cannot complete relevant questionaires
* Cognitive impairment
* Severe autonomic reflex disorder
* Severe muscle atrophy and joint contracture
* Cannot participate in spinal cord stimulation surgery or follow-up visits
* Life expectancy less than 12 months
* Abnormal blood or other physiological examinations that cannot conduct surgery, such as blood coagulation disorder or kidney/liver abnormalities
* Uncontrollable hypertension, heart diseases, respiratory diseases or took related medicine in last 3 months
* Unsuitable candidates in PI's perspective

Where it's running

  • National Engineering Laboratory for Neuromodulation
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Luming Li, PhD — National Engineering Laboratory for Neuromodulation
  • Study coordinator: Yang Lu, MD
  • Email: yanglu@btch.edu.cn
  • Phone: +8656119530

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.